Showing 1 - 9 results of 9 for search 'Marta Sobas', query time: 0.05s Refine Results
  1. 1
    Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar—Cases Series and a Review of the Literature

    Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar—Cases Series and a Review of the Literature by Marta Sobas, Maria Podolak-Dawidziak, Krzysztof Lewandowski, Michał Bator, Tomasz Wróbel

    Published 2021-10-01
    Get full text
    Article
  2. 2
    Creutzfeldt-Jakob Disease as a Reason for Neurological Deterioration in a Patient with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

    Creutzfeldt-Jakob Disease as a Reason for Neurological Deterioration in a Patient with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation by Magdalena Karasek, Melissa Szmukala, Joanna Bladowska, Jakub Ubysz, Halina Bielecka, Marta Sobas

    Published 2023-06-01
    Get full text
    Article
  3. 3
    P1053: NEUTROPHIL-TO-LYMPHOCYTE AND PLATELET-TO-LYMPHOCYTE RATIO AS NOVEL PROGNOSTIC BIOMARKES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

    P1053: NEUTROPHIL-TO-LYMPHOCYTE AND PLATELET-TO-LYMPHOCYTE RATIO AS NOVEL PROGNOSTIC BIOMARKES IN BCR-ABL NEGATIVE MYELOPROLIFERATIVE NEOPLASMS by Mirjana Cvetkovic, Jelena Ivanović, Isidora Arsenović, Mihailo Smiljanic, Magdalena Karasek, Olga Chyrko, Andrija Bogdanovic, Marta Sobas, Danijela Lekovic

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia

    Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia by Danijela Lekovic, Andrija Bogdanovic, Marta Sobas, Isidora Arsenovic, Mihailo Smiljanic, Jelena Ivanovic, Jelena Bodrozic, Vladan Cokic, Natasa Milic

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs

    Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs by Aleksandra Kaczorowska, Weronika Lamperska, Kaja Frączkowska, Jan Masajada, Sławomir Drobczyński, Marta Sobas, Tomasz Wróbel, Kinga Chybicka, Radosław Tarkowski, Sebastian Kraszewski, Halina Podbielska, Wojciech Kałas, Marta Kopaczyńska

    Published 2020-06-01
    Get full text
    Article
  6. 6
    Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis

    Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis by Naveen Pemmaraju, Claire Harrison, Vikas Gupta, Srdan Verstovsek, Bart Scott, Stephen T. Oh, Francesca Palandri, Haifa Kathrin Al‐Ali, Marta Sobas, Mary Frances McMullin, Ruben Mesa, Sarah Buckley, Karisse Roman‐Torres, Alessandro Vannucchi, Abdulraheem Yacoub

    Published 2022-11-01
    Get full text
    Article
  7. 7
    PLZF-RAR<sub>α</sub>, NPM1-RAR<sub>α</sub>, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review

    PLZF-RAR<sub>α</sub>, NPM1-RAR<sub>α</sub>, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review by Marta Sobas, Maria Carme Talarn-Forcadell, David Martínez-Cuadrón, Lourdes Escoda, María J. García-Pérez, Jose Mariz, María J. Mela-Osorio, Isolda Fernández, Juan M. Alonso-Domínguez, Javier Cornago-Navascués, Gabriela Rodríguez-Macias, María E. Amutio, Carlos Rodríguez-Medina, Jordi Esteve, Agnieszka Sokół, Thais Murciano-Carrillo, María J. Calasanz, Manuel Barrios, Eva Barragán, Miguel A. Sanz, Pau Montesinos

    Published 2020-05-01
    Get full text
    Article
  8. 8
    P491: DAY 14 MEASURABLE RESIDUAL DISEASE ASSESSMENT PREDICTS TREATMENT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY - RESULTS OF THE PALG-AML1/2016 STUDY

    P491: DAY 14 MEASURABLE RESIDUAL DISEASE ASSESSMENT PREDICTS TREATMENT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH INTENSIVE CHEMOTHERAPY - RESULTS OF THE PALG-AM... by Agnieszka Wierzbowska, Agnieszka Pluta, Anna Czyz, Magdalena Czemerska, Damian Mikulski, Piotr Stelmach, Marta Libura, Sebastian Giebel, Agnieszka Kopinska, Krzysztof Wozniczka, Grzegorz Helbig, Karol Wojcik, Malgorzata Razny, Marta Sobas, Tomasz Wróbel, Andrzej Szczepaniak, Lidia Gil, Magdalena Dutka, Maria Bieniaszewska, Jan Maciej Zaucha, Tomasz Gromek, Marek Hus, Edyta Cichocka, Janusz Halka, Elzbieta Patkowska, Jolanta Wozniak, Agata Obara, Agnieszka Kopacz, Katarzyna Dulik, Jerzy Holowiecki, Michał Soin, Wojciech Fendler, Andi Rustani, Justin Kaner, Nuria Mencia-Trinchant, Pinkal Desai, Sangmin Lee, Michael Samuel, Ellen Ritchie, Monica Guzman, Gail Roboz

    Published 2023-08-01
    Get full text
    Article
  9. 9
    P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE.

    P498: INCIDENCE, RISK FACTORS AND OUTCOMES OF SECOND NEOPLASMS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA: THE PETHEMA-PALG EXPERIENCE. by Marta Sobas, Wanda Knopinska-Posluszny, Beata Piątkowska-Jakubas, Gert Ossenkoppele, Flor García-Álvarez, María Elena Amutio Díez, Mar Caballero, David Martinez-Cuadrón, Eliana Aguiar, Jose Gonzalez Campos, Ana Garrido Diaz, Lorenzo Algarra, Olga Salamero, Javier de la Serna, Maria Jose Sayas Lloris, Manuel Mateo Perez Encinas, Susana Vives Polo, Veronica Gonzalez DE LA Calle, Jorge Labrador, Ana Inés Prado, Lucía Celebrin, Jiri Mayer, Graca Luiza O P Neto Vasconcelos Esteves, Almudena de Laiglesia, Juan Miguel Bergua Burgues, Maria Luz Amigo, Carlos Rodriguez Medina, Marta Polo, Agnieszka Pluta, Edyta Cichocka, Marek Skarupski, Miguel A Sanz, Pau Montesinos

    Published 2023-08-01
    Get full text
    Article

Search Tools: